Compare ARK Genomic Revolution ETF (ARKG) vs Lithium Americas Corp (LAC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Lithium Americas Corp — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Lithium Americas Corp trades at $3.3 (market cap $1.16B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | LAC | |
|---|---|---|
Sector | Sector/Thematic | Basic Materials |
52-Week High | $43.57 | $10.05 |
52-Week Low | $23.09 | $2.55 |
Market Cap | — | $1.16B |
Enterprise Value | — | $1.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Lithium Americas (LAC) trades at $3.32, down 6.74% on the day, reflecting ongoing bearish pressure. The stock shows mixed signals with a bearish technical trend but bullish oscillators like RSI at oversold levels. Fundamentally, the company remains unprofitable with negative net income of -$122.09 million in 2025, though it maintains a low P/B ratio of 0.87. Recent news highlights construction milestones at Thacker Pass and significant government funding interest in the rare earth sector.
LAC presents a high-risk, high-reward opportunity tied to its Thacker Pass project execution. Analyst consensus is cautiously optimistic with a $6.25 price target, but near-term risks include substantial capital needs, potential equity dilution, and persistent negative cash flow from operations. The stock's outlook hinges on successful project development and lithium market dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →
